Atlas market file · Etf · United States
Avantis U.S. Equity ETFAVUS
- Last close
- 130.62
- Change
- -0.15%
- 96-bar range
- 107.74 – 132.19
- As of
- 6 Aug 2026
Avantis U.S. Equity ETF is an exchange-traded fund listed as AVUS on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+39.70% over the window).
Source rail: Yahoo Finance chart API (AVUS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AVUS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AVUS public profile
Exchange-traded fund. Avantis U.S. Equity ETF is connected to current market context, cited company sources and its retained research file.
Avantis U.S. Equity ETF trades as AVUS on AMEX. Avantis U.S. Equity ETF (AVUS) has a latest verified close of 130.62, down 0.15%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. AVUS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Avantis U.S. Equity ETF today
The Avantis U.S. Equity ETF (AVUS) isn’t here to dazzle you with a clever ticker; it’s here to charge you 0.25% per year for the privilege of owning a slice of America’s middle-tier corporate backbone. The fund’s mandate is refreshingly straightforward: it tracks the CRSP U.S. Mid Cap Index, which means you’re not getting the S&P 500’s shimmering mega-caps or the Nasdaq’s tech circus, just the kind of companies that keep the lights on, the payrolls ticking, and the dividend checks flowing without the fanfare of a billion-dollar IPO splash. Mid-cap life isn’t glamorous, but it’s where the economy’s work happens-think regional banks, industrial suppliers, and regional healthcare chains that don’t make headlines but do make payrolls.
The issuer’s marketing is all about ‘accessing the full opportunity set of U.S. mid-cap stocks,’ which is the ETF world’s equivalent of selling a bicycle by promising ‘the entire environment of two wheels.’ In reality, AVUS is a fee-collection vehicle for a basket of 700-odd companies that collectively decide whether your grocery budget stays flat or creeps up next quarter. The fund’s expense ratio sits at 0.25%, which sounds modest until you remember that 25 basis points is the financial industry’s polite way of saying ‘we’ll take a quarter of your grocery budget for ourselves.’ The issuer’s glossy pitch might as well come with a free steak dinner: the actual meal is the fee, and the steak is whatever’s left after they’re done slicing.
The Avantis U.S. Equity ETF (AVUS) is officially filed with the U.S. Securities and Exchange Commission under the ticker AVUS, confirming the wrapper’s structure and existence. The fund’s mandate is to track the CRSP U.S. Mid Cap Index, a benchmark designed to capture the kind of companies that sit between the S&P 500’s skyscrapers and the Russell 2000’s skyscraper-sized egos. The expense ratio is 0.25%, a fee that arrives with the inevitability of a landlord’s rent demand and the subtlety of a billboard. The SEC’s EDGAR database confirms the fund’s filing details, while the Nasdaq listing confirms the market plumbing is in working order.
Liquidity is the quiet hero here: the fund trades on Nasdaq with enough daily volume to keep the market-makers from yawning, which is more than you can say for some of its thematic cousins that sound exciting until you try to exit at 3 p.m. on a Tuesday. The fund’s listing page is a parade of tickers, prices, and volumes that prove the wrapper exists and the plumbing works, even if the underlying companies are too busy shipping widgets to care about their day-to-day inclusion in a fund that charges a quarter-point for the pleasure.
What we don’t know is which of the 700-odd mid-caps in the basket is quietly dominating the portfolio or whether the fee is quietly dominating the returns. The fund’s marketing promises access to ‘the full opportunity set of U.S. mid-cap stocks,’ which is the ETF world’s way of selling a bicycle by promising ‘the entire environment of two wheels.’ The actual meal is the fee, and the steak is whatever’s left after they’re done slicing. The Nasdaq listing confirms the fund is tradable; the SEC filing confirms it’s official. The rest is just math you’re paying someone else to do.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AVUS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AVUS
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AVUS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AVUS FAQ
What is Avantis U.S. Equity ETF (AVUS)?Avantis U.S. Equity ETF (AVUS) has a latest verified close of 130.62, down 0.15%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Avantis U.S. Equity ETF (AVUS) has a latest verified close of 130.62, down 0.15%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AVUS?Avantis U.S. Equity ETF (AVUS) has a latest verified close of 130.62, down 0.15%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Avantis U.S. Equity ETF (AVUS) has a latest verified close of 130.62, down 0.15%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. AVUS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the AVUS page updated?The AVUS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AVUS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AVUS?The AVUS file starts with Nasdaq Trader and TradingView AMEX:AVUS. The page separates verified market context from company evidence and shows open evidence gaps instead...
The AVUS file starts with Nasdaq Trader and TradingView AMEX:AVUS. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AVUS?Yes. The workstation can open AVUS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AVUS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AVUS page investment advice?No. The AVUS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AVUS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
AVUS
Etf · evidence first